FMI
ZBH icon

F/M Investments’s Zimmer Biomet ZBH Stock Holding History

F/M Investments’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-14,464
Closed -$2.33M – 87
2022
Q2 		$2.33M Buy
+14,464
New +$1.72M 1.84% 21
2021
Q3 		– Sell
-14,898
Closed -$2.33M – 105
2021
Q2 		$2.33M Buy
+14,898
New +$2.41M 1.84% 21

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

F/M Investments's ZBH Position: Q3 2022 in Review

F/M Investments sold out of Zimmer Biomet (ZBH) in Q3 2022, closing a stake of 14,464 shares — an estimated $2.33M sold.

F/M Investments first reported a position in ZBH in Q2 2021 and held it in 2 quarters. The position peaked at $2.33M in Q2 2022. 919 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.

  • F/M Investments reported no remaining Zimmer Biomet position as of Q3 2022 after selling out during the quarter.
  • F/M Investments sold 14,464 Zimmer Biomet shares in Q3 2022, an estimated $2.33M.
  • F/M Investments first reported a position in Zimmer Biomet in Q2 2021 and held it in 2 quarters.
  • F/M Investments's Zimmer Biomet position peaked at $2.33M in Q2 2022.
  • 919 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.

Based on F/M Investments's 13F filing for Q3 2022, filed 4 Nov 2022.